Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Top Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime Segments | ||
By: PR Newswire Association LLC. - 23 Apr 2024 | Back to overview list |
|
Veeva Crossix helps 16 of the top 20 biopharmas more efficiently reach clinically relevant patients PLEASANTON, Calif., April 23, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 16 of the top 20 biopharmas are increasing media efficiency with Veeva Crossix Prime Segments, privacy-safe data helping life sciences brands reach highly-qualified health audiences. Since launching in April 2023, Veeva Crossix Prime Segments have helped top biopharmas reach consumers that are 10 times more qualified than standard health audience segments through digital media campaigns. "By using Veeva Crossix Prime Segments we have been able to reach much more precise patient populations in our targeted campaigns," said Scott Carberry, product director for IMBRUVICA, Johnson & Johnson. "Working with a trusted partner like Veeva Crossix affords us a breadth of targeting capabilities, and we've seen success reaching both treatment-naive as well as specific treating for adherence audiences." Veeva Crossix's privacy-safe health audience segments can help marketers achieve multiple campaign goals across any channel. Marketing teams can leverage Veeva Crossix Prime Segments to reach precise patient audiences and Veeva Crossix Reach Segments for broad awareness and ROI at scale. "A diverse set of health brands are using Veeva Crossix Prime Segments to reach their most qualified audiences — from broad treatment categories to rare diseases," said Jessica Daigle, head of Veeva Crossix Audience Segments. "Veeva Crossix is committed to delivering advanced solutions to help brands reach patients when it matters most." Veeva Crossix Prime Segments are custom-built to reach an advertiser's most qualified audience in a privacy-safe, HIPAA-compliant way. With data privacy embedded at its core, patented Veeva Crossix SafeMine technology ensures that Veeva Crossix Prime and Reach Segments protect patient privacy and are compliant with all applicable laws and regulations. Learn more about using data and analytics to improve marketing effectiveness at Veeva Commercial Summit in Boston, May 7-8. Life sciences industry professionals can register at veeva.com/CommercialSummit. Additional Information About Veeva Systems Veeva Forward-looking Statements Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/top-biopharma-brands-reach-audiences-10x-more-qualified-with-veeva-crossix-prime-segments-302124161.html SOURCE Veeva Systems |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |